Sharps Technology director granted 80,000 options at $6.41 (STSS)

Jason L. Monroe, a director of Sharps Technology Inc. (STSS), was granted an option to purchase 80,000 shares on 08/22/2025 with an exercise price of $6.41 per share.

Rhea-AI Filing Summary

Jason L. Monroe, a director of Sharps Technology Inc. (STSS), was granted an option to purchase 80,000 shares on 08/22/2025 with an exercise price of $6.41 per share. The option was granted under the company’s 2025 Equity Incentive Plan and will become 100% vested and exercisable on May 22, 2026. The Form 4 was signed by Mr. Monroe on 08/26/2025.

Positive

• Option grant disclosed: The Form 4 transparently reports an 80,000-share option award at a $6.41 exercise price.
• Clear vesting schedule: The option is stated to become 100% vested and exercisable on May 22, 2026.

Negative

• None.

Insights

Securities Analyst

TL;DR: Director received an 80,000-share option grant at $6.41, vesting fully in May 2026.

The filing documents a standard equity compensation event: an option award under the 2025 Equity Incentive Plan. The grant size and strike price are explicitly stated, as is the full vesting date of May 22, 2026. For investors, this is a disclosure of insider compensation and potential future issuance if exercised; the form does not disclose exercises, sales, or changes in beneficial ownership beyond the grant itself.

Corporate Governance Specialist

TL;DR: Director option award disclosed with clear vesting schedule and plan authority.

The Form 4 provides required Section 16 disclosure for a director-level equity award granted pursuant to the company’s 2025 Equity Incentive Plan. The filing specifies transaction date, exercise price, number of options, and vesting date. No additional context (such as prior holdings or relation to performance milestones) is provided in the document.

Insider Trade Summary

Net Buyer: 80,000 shares

Net Buy 1 txn

Insider Monroe Jason L.

Role Director

Bought 80,000 shs ($513K)

Type	Security	Shares	Price	Value
Purchase	Option (right to buy)	80,000	$6.41	$513K

Holdings After Transaction: Option (right to buy) — 80,000 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 4 filed for STSS (Sharps Technology Inc.) disclose?

The filing discloses that director Jason L. Monroe was granted an option to purchase 80,000 shares on 08/22/2025 at an exercise price of $6.41 per share.

When does the option granted to Jason L. Monroe vest and become exercisable?

The option will become 100% vested and exercisable on May 22, 2026.

Under what plan was the option for STSS granted?

The option was granted pursuant to the company’s 2025 Equity Incentive Plan, as stated in the filing.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Jason Monroe on 08/26/2025.

Does the Form 4 report an exercise or sale of shares by the insider?

No. The Form 4 reports an option grant (acquisition); it does not report any exercises or sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/26/2025 - 09:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Monroe Jason L.

(Last) (First) (Middle)

C/O SHARPS TECHNOLOGY, INC.

105 MAXESS ROAD, STE. 124

(Street)

MELVILLE NY 11747

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Option (right to buy)	08/22/2025		P		80,000	A	$6.41	80,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Granted pursuant to the Company's 2025 Equity Incentive Plan. The option will become 100% vested and exercisable on May 22, 2026.

	/s/ Jason Monroe	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.